Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DBV Technologies (DBVT) Inventory (2014 - 2020)

DBV Technologies (DBVT) reported Inventory of $3.7 million for Q2 2020, up 57.16% year-over-year from $2.3 million in Q3 2019, and up 62.98% on a QoQ basis from $2.3 million in Q4 2019.

DBV Technologies (DBVT) has 5 years of Inventory data on file, last reported at $3.7 million in Q2 2020.

  • Quarterly Inventory rose 57.16% year-over-year to $3.7 million in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $3.7 million (up 57.16% YoY) and the FY2019 annual result came in at $2.3 million, up 28.06% from the prior year.
  • Inventory advanced to $3.7 million in Q2 2020 per DBVT's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Inventory topped out at $3.7 million in Q2 2020 and bottomed at -$1.0 million in Q3 2018.
  • The 3-year median for Inventory is $2.3 million (2019), against an average of $1.9 million.
  • Peak annual rise in Inventory reached 340.99% in 2019, while the deepest fall reached 26.21% in 2019.
  • Tracing DBVT's Inventory over 3 years: stood at $1.8 million in 2018, then rose by 26.21% to $2.3 million in 2019, then jumped by 62.98% to $3.7 million in 2020.
  • Per Business Quant, the three latest DBVT Inventory figures stand at $3.7 million (Q2 2020), $2.3 million (Q4 2019), and $2.5 million (Q3 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 32.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.77 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.10 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 84.03 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 3.68 Mn
Dec 31, 2019 2.26 Mn
Sep 30, 2019 2.50 Mn
Jun 30, 2019 2.34 Mn
Dec 31, 2018 1.79 Mn
Sep 30, 2018 -1.04 Mn
Jun 30, 2015 152,332.67
Dec 31, 2014 155,068.09